QBench allows you to keep track of all your samples and where they are located in the workflow using a single system. QBench eliminates the need for spreadsheets, shared folders in the network, and paper-based tracking systems. You can view hundreds of PDF reports/COAs before publishing or emailing. You can generate barcodes and create labels that you can customize for your samples. Compatible with standard printers and scanners. QBench's billing module allows you to create and send invoices right from the system. You can see counts and latencies for different data types in QBench. This includes metrics like turnaround time, sample counts per test, sample delay, and many others. QBench makes it easy for you to gather the data your lab needs for the assays you perform.
Learn more
INTOO, the global career transition and outplacement division of Gi Group Holding, has supported more than 25,000 organizations over the last three decades in helping employees successfully navigate career change. Our award-winning solutions combine personalized, unlimited one-on-one coaching with intuitive digital tools designed to accelerate job searches—helping participants secure new roles 2.5 times faster than the national average while maintaining a 97% satisfaction rate. Serving clients in over 130 countries and 40+ languages, INTOO partners with HR leaders worldwide by delivering scalable support, actionable workforce insights, and a high-touch experience throughout every transition. At INTOO, we’re guided by one simple promise: to care more about your employees, your outcomes, and your success.
Our programs include:
- Seven-day-a-week access to expert career coaches for support with networking, LinkedIn optimization, personal branding, interview preparation, job search strategy, and more
- Personalized resume reviews designed to improve ATS performance and visibility
- Live daily webinars led by career experts on a wide range of job search and career development topics
- and more
Learn more
Paige
Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.
Learn more
Aiforia
Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.
Learn more
